Century Therapeutics, Inc. SEC filings IPSC
Century Therapeutics, Inc. has 444 filings in SEC EDGAR's recent list, going back to Mar 15, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 5, 2026 | Nov 3, 2026 |
| 144 | Notice of proposed sale | Nov 3, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 2, 2026 | Oct 2, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 11, 2026 |
| 144 | Notice of proposed sale | Sep 14, 2026 | — |
| 144 | Notice of proposed sale | Sep 14, 2026 | — |
| 4 | Insider transaction | Sep 10, 2026 | Sep 9, 2026 |
| 3 | Initial insider ownership | Sep 10, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| 144 | Notice of proposed sale | Sep 8, 2026 | — |
| 4 | Insider transaction | Aug 18, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 144 | Notice of proposed sale | Jun 12, 2026 | — |
| 4 | Insider transaction | Jun 9, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Other events
|
Jun 8, 2026 | Jun 8, 2026 |
| 144 | Notice of proposed sale | Jun 8, 2026 | — |
| 424B7 | Filing | May 21, 2026 | — |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 11, 2026 |
| ARS | Annual report to shareholders | Apr 16, 2026 | Dec 31, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Apr 10, 2026 | Dec 9, 2025 |
| 3 | Initial insider ownership | Apr 10, 2026 | Dec 9, 2025 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Other events
|
Mar 26, 2026 | Mar 26, 2026 |
| 424B5 | Prospectus supplement | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 16, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 144 | Notice of proposed sale | Mar 12, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 12, 2026 | Mar 12, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| 4 | Insider transaction | Feb 18, 2026 | Feb 13, 2026 |
| EFFECT | Filing | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2026 | — |
| CORRESP | Letter to the SEC | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| S-3 | Shelf registration | Feb 5, 2026 | — |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jan 23, 2026 | Jan 22, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 16, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 16, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 16, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 15, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| EFFECT | Filing | Jan 9, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 8, 2026 | Jan 7, 2026 |
| CORRESP | Letter to the SEC | Jan 7, 2026 | — |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| S-3/A | Filing | Jan 5, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 5, 2026 | — |
| 4 | Insider transaction | Dec 29, 2025 | Dec 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 29, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 3 | Initial insider ownership | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 144/A | Filing | Dec 9, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 9, 2025 | Dec 9, 2025 |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| DEFA14A | Additional proxy material | Dec 2, 2025 | — |
| DEF 14A | Proxy statement | Dec 2, 2025 | Jan 22, 2026 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| PRE 14A | Preliminary proxy statement | Nov 21, 2025 | Jan 22, 2026 |
| 4 | Insider transaction | Nov 20, 2025 | Nov 19, 2025 |
| 144 | Notice of proposed sale | Nov 20, 2025 | — |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Nov 5, 2025 | Nov 3, 2025 |
| 4 | Insider transaction | Sep 22, 2025 | Sep 18, 2025 |
| 4 | Insider transaction | Sep 10, 2025 | Sep 8, 2025 |
| 4 | Insider transaction | Sep 10, 2025 | Sep 8, 2025 |
| 4 | Insider transaction | Sep 10, 2025 | Sep 8, 2025 |
| 144 | Notice of proposed sale | Sep 8, 2025 | — |
| 144 | Notice of proposed sale | Sep 8, 2025 | — |
| 8-K |
Current report
Listing notice
|
Aug 29, 2025 | Aug 27, 2025 |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 4 | Insider transaction | Aug 18, 2025 | Aug 14, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 14, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 6, 2025 | Aug 4, 2025 |
| UPLOAD | Letter from the SEC | Jul 14, 2025 | — |
| S-3 | Shelf registration | Jul 10, 2025 | — |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
Jul 7, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 144 | Notice of proposed sale | Jun 9, 2025 | — |
| 144 | Notice of proposed sale | Jun 9, 2025 | — |
| 144 | Notice of proposed sale | Jun 9, 2025 | — |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 144 | Notice of proposed sale | May 16, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 7, 2025 | May 5, 2025 |
| 4 | Insider transaction | May 7, 2025 | May 5, 2025 |
| 144 | Notice of proposed sale | May 5, 2025 | — |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 12, 2025 |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 19, 2025 | Mar 19, 2025 |
| 10-K | Annual report | Mar 19, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 144 | Notice of proposed sale | Mar 10, 2025 | — |
| 144 | Notice of proposed sale | Mar 10, 2025 | — |
| 144 | Notice of proposed sale | Mar 10, 2025 | — |
| 8-K |
Current report
Listing notice
|
Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| 144 | Notice of proposed sale | Feb 18, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 144 | Notice of proposed sale | Feb 3, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Agreement ended
|
Dec 13, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 4, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 27, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 4 | Insider transaction | Nov 5, 2024 | Nov 4, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 5, 2024 | Nov 5, 2024 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 144 | Notice of proposed sale | Nov 4, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 25, 2024 | — |
| 4 | Insider transaction | Oct 16, 2024 | Oct 14, 2024 |
| 3 | Initial insider ownership | Oct 16, 2024 | Oct 14, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Oct 1, 2024 |
| 3 | Initial insider ownership | Oct 3, 2024 | Oct 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2024 | Sep 26, 2024 |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Aug 7, 2024 | Aug 5, 2024 |
| 4 | Insider transaction | Aug 7, 2024 | Aug 5, 2024 |
| 144 | Notice of proposed sale | Aug 5, 2024 | — |
| 4 | Insider transaction | Jul 31, 2024 | Jul 26, 2024 |
| 144 | Notice of proposed sale | Jul 26, 2024 | — |
| 4 | Insider transaction | Jul 25, 2024 | Jul 23, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IPSC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1850119
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.